Comparative Analysis of Multi-Drug Resistance Pattern of Rifampicin Sensitive and Resistant Mycobacterium Tuberculosis
Annals of King Edward Medical University · 30.06.2026 · 32 (2)
DOI: 10.21649/akemu.v32i2.6076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of King Edward Medical University, online erschienen am 30.06.2026. Verfasst von Misbah Rasheed und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a major global public health problem, particularly due to the increasing burden of drug-resistant strains. According to the World Health Organization, approximately 450,000 cases of rifampicin-resistant TB are reported annually worldwide. Rifampicin resistance is a key marker of multidrug-resistant TB (MDR-TB), which is also resistant to isoniazid, making effective treatment increasingly challenging.
Objective
This study aimed to compare the drug resistance patterns of rifampicin-sensitive (RIF-S) and rifampicin-resistant (RIF-R) Mycobacterium tuberculosis isolates. Methodology: A cross-sectional study was conducted on 400 TB-suspected patients aged 15–80 years (mean age: 42 ± 16 years). Sputum samples were analyzed using the Gene Xpert MTB/RIF assay for the detection of M. tuberculosis and drug resistance profiling.
Results
Out of 400 samples, 65 (16.25%) were MTB-positive, while 335 (83.75%) were MTB-negative. Among the MTB-positive cases, 52 (13%) were rifampicin-sensitive and 13 (3.25%) were rifampicin-resistant. Drug resistance patterns were assessed for six anti-tubercular drugs: isoniazid (INH), fluoroquinolones (FLQ), ethionamide (ETH), amikacin (AMK), kanamycin (KAN) and capreomycin (CAP). RIF-S isolates showed resistance to isoniazid (14), fluoroquinolones (19), amikacin (2), kanamycin (2), capreomycin (2), and ethionamide (2), while RIF-R isolates demonstrated resistance to isoniazid (7), fluoroquinolones (9), amikacin (1), kanamycin (1), capreomycin (1) and ethionamide (2).
Conclusion
The study highlights substantial resistance to isoniazid and fluoroquinolones in both rifampicin-sensitive and rifampicin-resistant TB cases, underscoring the need for comprehensive drug susceptibility testing to guide effective treatment regimens and strengthen TB control strategies.
Zitieren
APA
Rasheed, M., Huda, N. U., Shaukat, Z., Ahmed, U., Zia, A., & Ashraf, M. (2026). Comparative Analysis of Multi-Drug Resistance Pattern of Rifampicin Sensitive and Resistant Mycobacterium Tuberculosis. Annals of King Edward Medical University, 32(2). https://doi.org/10.21649/akemu.v32i2.6076
Vancouver
Rasheed M, Huda NU, Shaukat Z, Ahmed U, Zia A, Ashraf M. Comparative Analysis of Multi-Drug Resistance Pattern of Rifampicin Sensitive and Resistant Mycobacterium Tuberculosis. Annals of King Edward Medical University. 2026;32(2). doi:10.21649/akemu.v32i2.6076
BibTeX
@article{Rasheed2026,
author = {Rasheed, Misbah and Huda, Noor Ul and Shaukat, Zarqa and Ahmed, Umer and Zia, Amina and Ashraf, Muhammad},
title = {Comparative Analysis of Multi-Drug Resistance Pattern of Rifampicin Sensitive and Resistant Mycobacterium Tuberculosis},
journal = {Annals of King Edward Medical University},
year = {2026},
volume = {32},
number = {2},
doi = {10.21649/akemu.v32i2.6076}
}
EUVIMED